Joint effects between UDP-glucuronosyltransferase 1A7 genotype and dietary carcinogen exposure on risk of colon cancer

Cancer Epidemiology Biomarkers and Prevention

Volumn 14, Issue 7, 2005, Pages 1626-1632

  Butler, Lesley M ^a   Duguay, Yannick ^b   Millikan, Robert C ^c   Sinha, Rashmi ^e   Gagné, Jean François ^b   Sandler, Robert S ^c,d   Guillemette, Chantal ^b,f  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b LAVAL UNIVERSITY   (Canada)

^c The University of North Carolina at Chapel Hill   (United States)

^d UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^e NATIONAL CANCER INSTITUTE   (United States)

^f Université Laval   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

2 AMINO 3,4,8 TRIMETHYLIMIDAZO[4,5 F]QUINOXALINE; AMINE; CARCINOGEN; GLUCURONOSYLTRANSFERASE; GLUCURONOSYLTRANSFERASE 1A7; HETEROCYCLIC AMINE; IMIDAZOLE DERIVATIVE; POLYCYCLIC AROMATIC HYDROCARBON; QUINOXALINE DERIVATIVE; UNCLASSIFIED DRUG;

ADULT; AFRICAN AMERICAN; AGED; ALLELE; ARTICLE; CANCER RISK; COLON CANCER; CONTROLLED STUDY; COOKING; DETOXIFICATION; DIETARY INTAKE; EXPOSURE; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEAT; PRIORITY JOURNAL;

AGED; ALLELES; ANIMALS; CASE-CONTROL STUDIES; COLONIC NEOPLASMS; DIET; FEMALE; GENOTYPE; GLUCURONOSYLTRANSFERASE; HUMANS; MALE; MEAT; MIDDLE AGED; NORTH CAROLINA; RISK FACTORS;

EID: 22244453379     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-04-0682     Document Type: Article

References (59)

1. Anonymous. Benzo[a]pyrene. IARC Monogr Eval Carcinog Risks Hum 1983;32:211-24.
2. Anonymous. PhIP (2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine). IARC Monogr Eval Carcinog Risks Hum 1993;56:229-42.
3. Anonymous. MeIQx (2-amino-3/8-dimethylimidazo[4,5-f]quinoxaline). IARC Monogr Eval Carcinog Risks Hum 1993;56:211-28.
4. Keating GA, Bogen KT. Methods for estimating heterocyclic amine concentrations in cooked meats in the US diet. Food Chem Toxicol 2001;39:29-43.
5. Sinha R, Knize MG, Salmon CP, et al. Heterocyclic amine content of pork products cooked by different methods and to varying degrees of doneness. Food Chem Toxicol 1998;36:289-97.
6. Sinha R, Rothman N, Salmon CP, et al. Heterocyclic amine content in beef cooked by different methods to varying degrees of doneness and gravy made from meat drippings. Food Chem Toxicol 1998;36:279-87.
7. Lijinsky W. The formation and occurrence of polynuclear aromatic hydrocarbons associated with food. Mutat Res 1991;259:251-61.
8. Butler LM, Sinha R, Millikan RC, et al. Heterocyclic amines, meat intake, and association with colon cancer in a population-based study. Am J Epidemiol 2003;157:434-45.
9. Mackenzie PI, Owens IS, Burchell B, et al. The UDF glycosyltransferase gene superfamily: recommended nomenclature update based on evolutionary divergence. Pharmacogenetics 1997;7:255-69.
10. Malfatti MA, Felton JS. N-glucuronidation of 2-amino-1-methyl-6- phenylimidazo[4,5-b]pyridine (PhIP) and N-hydroxy-PhIP by specific human UDP-glucuronosyltransferases. Carcinogenesis 2001;22:1087-93.
11. Nowell SA, Massengill JS, Williams S, et al. Glucuronidation of 2-hydroxyamino-1-methyl-6-phenylimidazo[4, 5-b]pyridine by human microsomal UDP-glucuronosyltransferases: identification of specific UGT1A family isoforms involved. Carcinogenesis 1999;20:1107-14.
12. Styczynski PB, Blackmon RC, Groopman JD, Kensler TW. The direct glucuronidation of 2-amino-1-methyl-6-phenylimidazo[4,5-b] pyridine (PhIP) by human and rabbit liver microsomes. Chem Res Toxicol 1993;6:846-51.
13. Malfatti MA, Kulp KS, Knize MG, et al. The identification of [2-([14])C]2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine metabolites in humans. Carcinogenesis 1999;20:705-13.
14. 2-oxidized species of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in rat liver. Carcinogenesis 1991;12:2239-45.
15. Kaderlik KR, Mulder GJ, Turesky RJ, et al. Glucuronidation of N-hydroxy heterocyclic amines by human and rat liver microsomes. Carcinogenesis 1994;15:1695-701.
16. King RS, Kadlubar FF, Turesky RJ. Food borne carcinogens: heterocyclic amines. Chichester (England): John Wiley and Sons, Ltd.; 2000.
17. Gschaidmeier H, Seidel A, Burchell B, Bock KW. Formation of mono- and diglucuronides and other glycosides of benzo(a)pyrene-3,6-quinol by V79 cell-expressed human phenol UDP-glucuronosyltransferases of the UGT1 gene complex. Biochem Pharmacol 1995;49:1601-6.
18. Kim PM, Wells PG. Genoprotection by UDP-glucuronosyltransferases in peroxidase-dependent, reactive oxygen species-mediated micronucleus initiation by the carcinogens 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and benzo[a]pyrene. Cancer Res 1996;56:1526-32.
19. Strassburg CP, Vogel A, Kneip S, Tukey RH, Manns MP. Polymorphisms of the human UDP-glucuronosyltransferase (UGT) 1A7 gene in colorectal cancer. Gut 2002;50:851-6.
20. Yueh MF, Nguyen N, Famourzadeh M, et al. The contribution of UDP-glucuronosyltransferase 1A9 on CYP1A2-mediated genotoxicity by aromatic and heterocyclic amines. Carcinogenesis 2001;22:943-50.
21. Guillemette C, Ritter JK, Auyeung DJ, Kessler FK, Housman DE. Structural heterogeneity at the UDP-glucuronosyltransferase 1 locus: functional consequences of three novel missense mutations in the human UGT1A7 gene. Pharmacogenetics 2000;10:629-44.
22. Grove AD, Kessler FK, Metz RP, Ritter JK. Identification of a rat oltipraz-inducible UDP-glucuronosyltransferase (UGT1A7) with activity towards benzo(a)pyrene-7,8-dihydrodiol. J Biol Chem 1997;272:1621-7.
23. Zheng Z, Fang JL, Lazarus P. Glucuronidation: an important mechanism for detoxification of benzo[a]pyrene metabolites in aerodigestive tract tissues. Drug Metab Dispos 2002;30:397-403.
24. Basu NK, Kubota S, Meselhy MR, et al. Gastrointestinally distributed UDP-glucuronosyltransferase 1A10, which metabolizes estrogens and nonsteroidal anti-inflammatory drugs, depends upon phosphorylation. J Biol Chem 2004;279:28320-9.
25. Weinberg CR, Sandler DP. Randomized recruitment in case-control studies. Am J Epidemiol 1991;134:421-32.
26. Aldrich TE, Vann D, Moorman PG, Newman B. Rapid reporting of cancer incidence in a population-based study of breast cancer: one constructive use of a central cancer registry. Breast Cancer Res Treat 1995;35:61-4.
27. Block G, Hartman AM, Dresser CM, Carroll MD, Cannon J, Gardner L. A data-based approach to diet questionnaire design and testing. Am J Epidemiol 1986;124:453-69.
28. Sinha R, Rothman N. Exposure assessment of heterocyclic amines (HCAs) in epidemiologic studies. Mutat Res 1997;376:195-202.
29. Kazerouni N, Sinha R, Hsu CH, Greenberg A, Rothman N. Analysis of 200 food items for benzo[a]pyrene and estimation of its intake in an epidemiologic study. Food Chem Toxicol 2001;39:423-36.
30. Zheng Z, Park JY, Guillemette C, Schantz SP, Lazarus P. Tobacco carcinogen-detoxifying enzyme UGT1A7 and its association with orolaryngeal cancer risk. J Natl Cancer Inst 2001;93:1411-8.
31. Villeneuve L, Girard H, Fortier L-C, Gagne JF, Guillemette C. Novel functional polymorphisms in the UGT1A7 and UGT1A9 glucuronidating enzymes in Caucasian and African-American subjects and their impact on the metabolism of 7-ethyl-10-hydroxycamptothecin and flavopiridol anti cancer drugs. J Pharmacol Exp Ther 2003;307:117-28.
32. Cavalli-Sforza LL, Bodmer WF. The genetics of human populations. San Francisco: W. H. Freeman; 1971.
33. Willett W, Stampfer MJ. Total energy intake: implications for epidemiologic analyses. Am J Epidemiol 1986;124:17-27.
34. Satia-Abouta J, Galanko JA, Potter JD, Ammerman A, Martin CF, Sandler RS. Associations of total energy and macronutrients with colon cancer risk in African Americans and Whites: results from the North Carolina colon cancer study. Am J Epidemiol 2003;158:951-62.
35. Satia-Abouta J, Galanko JA, Martin CF, Potter JD, Ammerman A, Sandler RS. Associations of micronutrients with colon cancer risk in African Americans and Whites: results from the North Carolina Colon Cancer Study. Cancer Epidemiol Biomarkers Prev 2003;12:747-54.
36. Breslow N, Day N. Statistical methods in cancer research: the analysis of case-control studies. Lyon: IARC; 1980.
37. Assmann SF, Hosmer DW, Lemeshow S, Mundt KA. Confidence intervals for measures of interaction. Epidemiology 1996;7:286-90.
38. Hosmer DW, Lemeshow S. Confidence interval estimation of interaction. Epidemiology 1992;3:452-6.
39. Iqbal S, Lenz HJ. Determinants of prognosis and response to therapy in colorectal cancer. Curr Oncol Rep 2001;3:102-8.
40. Strassburg CP, Nguyen N, Manns MP, Tukey RH. UDP-glucuronosyltransferase activity in human liver and colon. Gastroenterology 1999;116:149-60.
41. Fang JL, Beland FA, Doerge DR, et al. Characterization of benzo(a)pyrene-trans-7,8-dihydrodiol glucuronidation by human tissue microsomes and overexpressed UDP-glucuronosyltransferase enzymes. Cancer Res 2002; 62:1978-86.
42. Girard H, Thibaudeau J, Court MH, Fortier LC, Villeneuve L, Guillemette C. UGT1A1 promoter polymorphism as an important determinant of heterocyclic amine detoxification. In: Vancouver: ISSX; 2004.
43. Malfatti MA, Felton JS. Human UDP-glucuronosyltransferase 1A1 is the primary enzyme responsible for the N-glucuronidation of N-hydroxy-PhIP in vitro. Chem Res Toxicol 2004;17:1137-44.
44. Sugatani J, Yamakawa K, Tonda E, et al. The induction of human UDP-glucuronosyltransferase 1A1 mediated through a distal enhancer module by flavonoids and xenobiotics. Biochem Pharmacol 2004;67:989-1000.
45. van der Logt EM, Roelofs HM, Nagengast FM, Peters WH. Induction of rat hepatic and intestinal UDP-glucuronosyltransferases by naturally occurring dietary anticarcinogens. Carcinogenesis 2003;24:1651-6.
46. Sinha R, Rothman N, Brown ED, et al. High concentrations of the carcinogen 2-amino-1-methyl-6-phenylimidazo-[4,5-b]pyridine (PhIP) occur in chicken but are dependent on the cooking method. Cancer Res 1995;55:4516-9.
47. Layton DW, Bogen KT, Knize MG, Hatch FT, Johnson VM, Felton JS. Cancer risk of heterocyclic amines in cooked foods: an analysis and implications for research. Carcinogenesis 1995;16:39-52.
48. Dosemeci M, Wacholder S, Lubin JH. Does nondifferential misclassification of exposure always bias a true effect toward the null value? Am J Epidemiol 1990;132:746-8.
49. Ehmer U, Vogel A, Schutte JK, Krone B, Manns MP, Strassburg CP. Variation of hepatic glucuronidation: novel functional polymorphisms of the UDP-glucuronosyltransferase UGT1A4. Hepatology 2004;39:970-7.
50. Ciotti M, Marrone A, Potter C, Owens IS. Genetic polymorphism in the human UGT1A6 (planar phenol) UDP-glucuronosyltransferase: pharmacological implications. Pharmacogenetics 1997;7:485-95.
51. Huang YH, Galijatovic A, Nguyen N, et al. Identification and functional characterization of UDP-glucuronosyltransferases UGT1A8*1, UGT1A8*2 and UGT1A8*3. Pharmacogenetics 2002;12:287-97.
52. Girard H, Court MH, Bernard O, et al. Identification of common polymorphisms in the promoter of the UGT1A9 gene: evidence that UGT1A9 protein and activity levels are strongly genetically controlled in the liver. Pharmacogenetics 2004;14:501-15.
53. Elahi A, Bendaly J, Zheng Z, et al. Detection of UGT1A10 polymorphisms and their association with orolaryngeal carcinoma risk. Cancer 2003;98:872-80.
54. Gong QH, Cho JW, Huang T, et al. Thirteen UDPglucuronosyltransferase genes are encoded at the human UGT1 gene complex locus. Pharmacogenetics 2001;11:357-68.
55. Kohle C, Mohrle B, Munzel PA, et al. Frequent co-occurrence of the TATA box mutation associated with Gilbert's syndrome (UGT1A1*28) with other polymorphisms of the UDP-glucuronosyltransferase-1 locus (UGT1A6*2 and UGT1A7*3) in Caucasians and Egyptians. Biochem Pharmacol 2003;65:1521-7.
56. Fang JL, Lazarus P. Correlation between the UDP-glucuronosyltransferase (UGT1A1) TATAA box polymorphism and carcinogen detoxification phenotype: significantly decreased glucuronidating activity against benzo(a)pyrene-7,8- dihydrodiol(-) in liver microsomes from subjects with the UGT1A1*28 variant. Cancer Epidemiol Biomarkers Prev 2004;13:102-9.
57. Vineis P, Bartsch H, Caporaso N, et al. Genetically based N-acetyltransferase metabolic polymorphism and low-level environmental exposure to carcinogens. Nature 1994;369:154-6.
58. Vineis P, Martone T. Genetic-environmental interactions and low-level exposure to carcinogens. Epidemiology 1995;6:455-7.
59. Tukey RH, Strassburg CP. Human UDP-glucuronosyltransferases: metabolism, expression, and disease. Annu Rev Pharmacol Toxicol 2000; 40:581-616.